Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.
Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.
复制标题
DOI:
10.1016/j.pharmthera.2008.06.002
复制
发表时间:
2008-09
影响因子:
13.5
通讯作者:
Carnes C
中科院分区:
文献类型:
--
作者:
Györke S;Carnes C
In the heart, Ca2+ released from the intracellular Ca2+ storage site, the sarcoplasmic reticulum (SR), is the principal determinant of cardiac contractility. SR Ca2+ release is controlled by dedicated molecular machinery, composed of the cardiac ryanodine receptor (RyR2) and a number of accessory proteins, including FKBP12.6, calsequestrin (CASQ2), triadin (TRD) and junctin (JN). Acquired and genetic defects in the components of the release channel complex result in a spectrum of abnormal Ca2+ release phenotypes ranging from arrhythmogenic spontaneous Ca2+ releases and Ca2+ alternans to the uniformly diminished systolic Ca2+ release characteristic of heart failure. In this article, we will present an overview of the structure and molecular components of the SR and Ca2+ release machinery and its modulation by different intracellular factors, such as Ca2+ levels inside the SR as well as phosphorylation and redox modification of RyR2s.We will also discuss the relationships between abnormal SR Ca2+ release and various cardiac disease phenotypes, including, arrhythmias and heart failure, and consider SR Ca2+ release as a potential therapeutic target.
登录
查看更多内容
影响因子:
4.8
作者:
Aracena-Parks, Paula;Goonasekera, Sanjeewa A.;Hamilton, Susan L.
通讯作者:
Hamilton, Susan L.
DOI:
10.1196/annals.1341.008
发表时间:
2005-01-01
期刊:
COMMUNICATIVE CARDIAC CELL
影响因子:
--
作者:
Bers, DM;Guo, T
通讯作者:
Guo, T
影响因子:
64.5
作者:
BRILLANTES, AMB;ONDRIAS, K;MARKS, AR
通讯作者:
MARKS, AR
影响因子:
5.5
作者:
ALLEN, DG;EISNER, DA;ORCHARD, CH
通讯作者:
ORCHARD, CH
DOI:
10.1152/ajpcell.1997.272.5.c1726
发表时间:
1997-05-01
影响因子:
5.5
作者:
Barg, S;Copello, JA;Fleischer, S
通讯作者:
Fleischer, S